Literature DB >> 16378779

Low-risk patients admitted with community-acquired pneumonia.

Thomas J Marrie1, Jane Q Huang.   

Abstract

PURPOSE: To describe the natural history of community-acquired pneumonia in the subset of a large cohort of patients at low risk for mortality who were admitted to the hospital.
METHODS: Prospective observational study of all patients at low risk for mortality (risk classes I and II) who presented to 6 hospitals and 1 emergency department in Edmonton, Alberta, Canada with a diagnosis of possible community-acquired pneumonia from November 15, 2000, to November 14, 2002.
RESULTS: A total of 586/3065 (19.1%) low-risk patients (Fine criteria) were admitted, 48.4% of whom stayed more than 5 days. Multivariate analysis revealed that patients who were admitted were more likely to be female, to have presented at Site B, which serves an inner city population, to have diminished premorbid functional status, to have comorbidities likely to be made worse by pneumonia (chronic obstructive pulmonary disease, asthma, heart disease, inflammatory bowel disease), and to suffer from substance abuse or psychiatric illness. A respiratory rate of >/=28 breaths per minute, and symptoms of shaking chills, shortness of breath, nausea or diarrhea were the remaining factors predicting admission. Nineteen percent of the patients suffered one or more complications, the most serious of which was progression of the pneumonia, resulting in respiratory failure necessitating mechanical ventilation in 2.4% and empyema in 1.4%. Four patients had lung cancer, and 1 had cancer of the vocal cords. Thirty-one percent of those who were admitted were still unable to eat or drink enough to maintain hydration by hospital day 5 or on discharge day.
CONCLUSIONS: One in 5 patients at low risk for mortality were admitted to the hospital and half stayed more than 5 days; 19% suffered 1 or more complications. Our data emphasize the need for better rules to guide the admission decision and the importance of physician judgment in this decision.

Entities:  

Mesh:

Year:  2005        PMID: 16378779     DOI: 10.1016/j.amjmed.2005.06.035

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

2.  Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial.

Authors:  Jose Labarere; Roslyn A Stone; D Scott Obrosky; Donald M Yealy; Thomas P Meehan; Thomas E Auble; Jonathan M Fine; Louis G Graff; Michael J Fine
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

3.  Assessment of pneumonia in older adults: effect of functional status.

Authors:  Lona Mody; Rongjun Sun; Suzanne F Bradley
Journal:  J Am Geriatr Soc       Date:  2006-07       Impact factor: 5.562

4.  Lysophosphatidylcholine as a prognostic marker in community-acquired pneumonia requiring hospitalization: a pilot study.

Authors:  W H Cho; H J Yeo; S H Yoon; S E Lee; D S Jeon; Y S Kim; S J Lee; E J Jo; J H Mok; M H Kim; K U Kim; K Lee; H K Park; M K Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-30       Impact factor: 3.267

5.  The value of prognostic indices for pneumonia.

Authors:  Jennie Johnstone; Sumit R Majumdar; Thomas J Marrie
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 6.  Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia.

Authors:  Brad Spellberg; George H Talbot; Eric P Brass; John S Bradley; Helen W Boucher; David N Gilbert
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

Review 7.  Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies.

Authors:  Vicente F Corrales-Medina; Kathryn N Suh; Gregory Rose; Julio A Chirinos; Steve Doucette; D William Cameron; Dean A Fergusson
Journal:  PLoS Med       Date:  2011-06-28       Impact factor: 11.069

8.  Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.

Authors:  Reiko Sato; Gabriel Gomez Rey; Stephanie Nelson; Brett Pinsky
Journal:  Appl Health Econ Health Policy       Date:  2013-06       Impact factor: 2.561

9.  The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States.

Authors:  Rodrigo Cavallazzi; Stephen Furmanek; Forest W Arnold; Leslie A Beavin; Richard G Wunderink; Michael S Niederman; Julio A Ramirez
Journal:  Chest       Date:  2020-04-13       Impact factor: 10.262

10.  Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom.

Authors:  Dionne Cw Braeken; Gernot Gu Rohde; Frits Me Franssen; Johanna Hm Driessen; Tjeerd P van Staa; Patrick C Souverein; Emiel Fm Wouters; Frank de Vries
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.